0.0066
0.0000
(0.00%)
At close: January 23 at 7:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
265.8090
288.2720
235.4490
138.7470
65.9780
Cost of Revenue
132.4460
204.0470
253.1690
384.2000
3.5790
Gross Profit
133.3630
84.2250
-17.7200
-245.4530
62.3990
Operating Expense
1,257.8030
1,460.5390
1,622.8660
1,543.7550
4,187.0370
Operating Income
-1,124.4400
-1,376.3140
-1,640.5860
-1,789.2080
-4,124.6380
Net Non Operating Interest Income Expense
9.9760
-263.8390
-360.0770
-269.4170
-119.6880
Other Income Expense
-26.0900
4.7790
532.7870
-3,088.3870
-695.7810
Pretax Income
-1,140.5540
-1,635.3740
-1,467.8760
-5,147.0120
-4,940.1070
Net Income Common Stockholders
-1,140.5540
-1,635.3740
-1,467.8760
-5,147.0120
-4,940.1070
Diluted NI Available to Com Stockholders
-1,140.5540
-1,635.3740
-1,467.8760
-5,147.0120
-4,940.1070
Basic EPS
-0.01
-0.01
-0.01
-0.04
-0.04
Diluted EPS
-0.01
-0.01
-0.01
-0.04
-0.04
Basic Average Shares
354,836.3780
219,299.3780
168,886.8720
148,504.5380
123,931.3390
Diluted Average Shares
354,836.3780
219,299.3780
168,886.8720
148,504.5380
123,931.3390
Rent Expense Supplemental
--
--
2.1060
--
--
Total Expenses
1,390.2490
1,664.5860
1,876.0350
1,927.9550
4,190.6160
Net Income from Continuing & Discontinued Operation
-1,140.5540
-1,635.3740
-1,467.8760
-5,147.0120
-4,940.1070
Normalized Income
-1,078.2150
-1,676.9800
-2,018.1770
-2,153.6070
-4,323.5720
Interest Expense
-9.9760
263.8390
360.0770
269.4170
119.6880
Net Interest Income
9.9760
-263.8390
-360.0770
-269.4170
-119.6880
EBIT
-1,150.5300
-1,371.5350
-1,107.7990
-4,877.5950
-4,820.4190
EBITDA
-1,037.5860
-1,221.7910
-811.4740
-4,049.2200
-4,106.6780
Reconciled Cost of Revenue
132.4470
204.0480
253.1690
384.2000
3.5770
Reconciled Depreciation
112.9430
149.7430
296.3250
828.3750
713.7410
Net Income from Continuing Operation Net Minority Interest
-1,140.5540
-1,635.3740
-1,467.8760
-5,147.0120
-4,940.1070
Total Unusual Items Excluding Goodwill
-62.3390
41.6060
550.3010
-2,993.4050
-616.5350
Total Unusual Items
-62.3390
41.6060
550.3010
-2,993.4050
-616.5350
Normalized EBITDA
-975.2470
-1,263.3970
-1,361.7750
-1,055.8150
-3,490.1430
12/31/2020 - 2/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0NN.BE Avicanna Inc
0.1870
-8.33%
ROMJF Rubicon Organics Inc.
0.2810
0.00%
LOVFF Cannara Biotech Inc.
0.6200
0.00%
DHBUF Delivra Health Brands Inc.
0.0154
+14.98%
DLTNF Delta 9 Cannabis Inc.
0.0080
0.00%
DBCCF Decibel Cannabis Company Inc.
0.0506
+1.20%
PROC Procaps Group S.A.
1.6500
0.00%
AVCN.TO Avicanna Inc.
0.2800
-9.68%
SNOA Sonoma Pharmaceuticals, Inc.
2.8400
+7.58%
ACB.TO Aurora Cannabis Inc.
5.57
+0.36%